Ribavirin
Ribavirin
Definition
A synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses. Ribavirin is incorporated into viral RNA, thereby inhibiting viral RNA synthesis, inducing viral genome mutations, and inhibiting normal viral replication.
Also known as 1-.beta.-D-Ribofuranosyl-1H-1,2, 4-triazole-3-carboxamide, 1-Beta-D-ribofuranosyl-1,2,4-triazolo-3-carboxamide, 1-Beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide, Copegus, ICN 1229, ICN-1229, Rebetol, RIBA, RIBAVIRIN, RTCA, Viramide, Virazid, Virazole — per NCIT
Also identified as
- ATC J05AP01 per RXNORM
- NCIT NCIT:C807 per NCIT
- SCTID 35063004 per RXNORM
- SCTID 387188005 per RXNORM
- UNII 49717AWG6K per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Chronic hepatitis C virus infection | may treat | MEDRT · Public domain (U.S. Government work) |
| Pharyngoconjunctival fever | may treat | MEDRT · Public domain (U.S. Government work) |
| Respiratory syncytial virus infectious disease | may treat | MEDRT · Public domain (U.S. Government work) |
| West Nile fever | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Lungs | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Respiratory system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.